Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

GENERALIZATION ERROR BOUNDS OF DYNAMIC TREATMENT REGIMES IN PENALIZED REGRESSION-BASED LEARNING.

Annals of statistics·2026
Same author

A SEQUENTIAL SIGNIFICANCE TEST FOR TREATMENT BY COVARIATE INTERACTIONS.

Statistica Sinica·2026
Same author

Comparing Adaptive Interventions under a General Sequential Multiple Assignment Randomized Trial Design via Multiple Comparisons with the Best.

Journal of statistical planning and inference·2026
Same author

Cryptotanshinone Directly Targets MEK1 to Inhibit Migration and Invasion of Breast Cancer Cells Through Down-Regulating ERK/EMT Axis.

Phytotherapy research : PTR·2026
Same author

Formation mechanism, detection methods and control strategies of warmed-over flavor in meat and meat products of livestock and poultry: A comprehensive review and future perspectives.

Food chemistry·2026
Same author

Developing and Testing a Brief Mindfulness Just-in-Time Adaptive Intervention to Reduce Stress Among Caregivers of People With Dementia: Quasi-Experimental Study.

JMIR aging·2026
Same journal

Towards a Unified Theory for Semiparametric Data Fusion with Individual-Level Data.

Annals of statistics·2026
Same journal

One-Step Estimation of Differentiable Hilbert-Valued Parameters.

Annals of statistics·2026
Same journal

EFFICIENT AND MULTIPLY ROBUST RISK ESTIMATION UNDER GENERAL FORMS OF DATASET SHIFT.

Annals of statistics·2026
Same journal

TESTING HIGH-DIMENSIONAL REGRESSION COEFFICIENTS IN LINEAR MODELS.

Annals of statistics·2026
Same journal

COUNTERFACTUAL INFERENCE IN SEQUENTIAL EXPERIMENTS.

Annals of statistics·2026
See all related articles

Related Experiment Videos

PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Min Qian1, Susan A Murphy

  • 1Department of Statistics, University of Michigan, Ann Arbor, MI, 48109.

Annals of Statistics
|June 14, 2011
PubMed
Summary
This summary is machine-generated.

This study introduces a method for creating personalized treatment rules using clinical trial data. It aims to optimize patient outcomes by selecting the best treatment based on individual characteristics, improving treatment efficacy.

Related Experiment Videos

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Personalized Medicine

Background:

  • Patient response to illness treatment is often heterogeneous.
  • Individualized treatment rules are gaining traction for tailored therapies.
  • Clinical trial data offers a valuable resource for developing these rules.

Purpose of the Study:

  • To construct an individualized treatment rule that maximizes mean patient response using clinical trial data.
  • To address computational challenges in optimizing treatment rules with complex objective functions.
  • To incorporate variable selection for cost-effectiveness and interpretability in treatment rules.

Main Methods:

  • Utilized clinical trial data for individualized treatment rule construction.
  • Employed l(1) penalized least squares for estimation.
  • Developed a finite sample upper bound to justify the estimation approach.

Main Results:

  • Proposed an estimation method based on l(1) penalized least squares.
  • Provided theoretical justification for the method's performance.
  • Addressed the challenge of selecting a parsimonious set of variables for treatment rules.

Conclusions:

  • The proposed method offers a robust approach to developing individualized treatment rules.
  • This methodology can enhance treatment efficacy by personalizing therapy selection.
  • The approach balances statistical performance with practical considerations like interpretability and cost.